Article
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Medicina (Kaunas, Lithuania) - 19 May 2021
Imai Hisao, Onozato Ryoichi, Ginnan Maiko, Kobayashi Daijiro, Kaira Kyoichi, Minato Koichi
Abstract excerpt
Background and Objective: Patients with advanced non-small-cell lung cancer (NSCLC) harboring sensitizing epidermal growth factor receptor (EGFR) mutations show a good response to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). The subsequent treatments influence the evaluability of the efficacy of front-line therapy on overall survival (OS). Consequently, we evaluated the associations of relapse-free survival (RFS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.